Sr One Capital Management, LLCinsider trades
In SEC Form 4 filings, Sr One Capital Management, LLC is listed as 10% owner of ADARx Pharmaceuticals, Inc. (ADRX). In the last 90 days, Sr One Capital Management, LLC bought $27.20M of ADARx Pharmaceuticals, Inc. (ADRX) on the open market and sold none. The largest purchase was $10.07M of ADARx Pharmaceuticals, Inc. (ADRX) on Sep 28. Took part in a cluster buy; the latest at ADARx Pharmaceuticals, Inc. (ADRX), where 5 insiders bought within 1 day, ending Sep 28.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| ADRXADARx Pharmaceuticals, Inc. | 10% owner | 15 | Sep 29 |
Cluster buys
- ADRX: 5 insiders bought $87.75M between Sep 28.
Form 4 historysince 2026-09-29
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 29 | C | 3,334,938 | not reported | not reported | 3,334,938 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 29 | C | 1,113,666 | not reported | not reported | 4,448,604 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 29 | C | 512,897 | not reported | not reported | 4,961,501 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 29 | P | 592,593 | $17.00 | Purchase +$10,074,081 | 5,554,094 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 29 | C | 1,538,691 | not reported | not reported | 1,538,691 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 29 | P | 414,814 | $17.00 | Purchase +$7,051,838 | 1,953,505 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 29 | C | 1,667,468 | not reported | not reported | 1,667,468 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 29 | C | 169,001 | not reported | not reported | 1,836,469 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 29 | P | 592,593 | $17.00 | Purchase +$10,074,081 | 592,593 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 29 | C · derivative | 3,907,547 | $0.00 | $0 | not reported | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 29 | C · derivative | 1,304,883 | $0.00 | $0 | not reported | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 29 | C · derivative | 600,962 | $0.00 | $0 | not reported | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 29 | C · derivative | 1,802,885 | $0.00 | $0 | not reported | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 29 | C · derivative | 1,953,773 | $0.00 | $0 | not reported | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 29 | C · derivative | 198,019 | $0.00 | $0 | not reported | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.